Inflammopharmacology

2.1k papers and 36.7k indexed citations i.

About

The 2.1k papers published in Inflammopharmacology in the last decades have received a total of 36.7k indexed citations. Papers published in Inflammopharmacology usually cover Molecular Biology (628 papers), Pharmacology (404 papers) and Pharmacology (308 papers) specifically the topics of Inflammatory mediators and NSAID effects (227 papers), Pharmacological Effects of Natural Compounds (169 papers) and Helicobacter pylori-related gastroenterology studies (126 papers). The most active scholars publishing in Inflammopharmacology are K. D. Rainsford, Walter F. Kean, J. N. Sharma, Abbas Al-Omran, Subramanian S. Parvathy, Randall E. Harris, M. W. Whitehouse, Ian Edwin Cock, Sneha Hariharan and S. Selvakumar.

In The Last Decade

Fields of papers published in Inflammopharmacology

Since Specialization
EngineeringComputer SciencePhysics and AstronomyMathematicsEarth and Planetary SciencesEnergyEnvironmental ScienceMaterials ScienceChemical EngineeringChemistryAgricultural and Biological SciencesVeterinaryDecision SciencesArts and HumanitiesBusiness, Management and AccountingSocial SciencesPsychologyEconomics, Econometrics and FinanceHealth ProfessionsDentistryMedicineBiochemistry, Genetics and Molecular BiologyNeuroscienceNursingImmunology and MicrobiologyPharmacology, Toxicology and Pharmaceutics

This network shows the specialization of papers published in Inflammopharmacology. Nodes represent fields, and links connect fields that are likely to share authors.

Countries where authors publish in Inflammopharmacology

Since Specialization
Total citations of papers

This map shows the geographic distribution of research published in Inflammopharmacology. It shows the number of citations received by papers published by authors working in each country. You can also color the map by specialization and compare the number of papers published in Inflammopharmacology with the expected number of papers based on a country's size and research output (numbers larger than one mean the country's share of papers is larger than expected).

Rankless by CCL
2025